Cellular Plasticity in Malignant Transformation: Mesothelial Cells

July 6, 2026 | Comments Off on Cellular Plasticity in Malignant Transformation: Mesothelial Cells

Pathobiology 2026 April 29 [Link] Claire W Michael, Ben Davidson Abstract Background: Mesothelial proliferations range from reactive lesions to benign and malignant tumors, bearing witness to the plasticity of these…

Paraneoplastic Brachial Amyotrophic Diplegia and Encephalitis With Ma2-IgG During Immune Checkpoint Inhibitor Use for Mesothelioma: A Case Report

July 3, 2026 | Comments Off on Paraneoplastic Brachial Amyotrophic Diplegia and Encephalitis With Ma2-IgG During Immune Checkpoint Inhibitor Use for Mesothelioma: A Case Report

JTO Clinical and Research Reports 2026 March 6 [Link] Sanem Pinar Uysal, Shervin Badihian, Karlo Toljan, Nirmal Andrapalliyal, James Stevenson, Jonathan Lee, Amy Kunchok Abstract Background: Immune checkpoint inhibitors (ICIs)…

Immunotherapy resistance and strategies in malignant pleural mesothelioma

July 2, 2026 | Comments Off on Immunotherapy resistance and strategies in malignant pleural mesothelioma

Cancer Drug Resistance 2026 March 26 [Link] Wanyi Xia, Yulong Zhang, Juanzhi Zhao, Xiaoli Tan, Shaolong Ju, Wei Zou, Chaoqun Chen, Chunwei Li, Yanghua Xu, Yingming Peng, Shengqiao Li Abstract…

Multiplexed single-cell and spatial profiling reveal B cells and tertiary lymphoid structures as prognostic indicators in pleural mesothelioma

July 1, 2026 | Comments Off on Multiplexed single-cell and spatial profiling reveal B cells and tertiary lymphoid structures as prognostic indicators in pleural mesothelioma

British Journal of Cancer 2026 July [Link] Angelica Rigutto, Nicolás G Núñez, Jenny C Kienzler, Isabelle Opitz, Mayura Meerang, Martina Haberecker, Nadine Fournier, Joao Lourenço, Raphael Gottardo, Karina Silina, Anurag…

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

June 30, 2026 | Comments Off on Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

Nature Genetics 2026 May [Link] Luana Calabrò, Francesca P Caruso, Alessia Covre, Teresa M R Noviello, Maria F Lofiego, Rossella Tufano, Luigi Ferraro, Piera Grisolia, Antonio De Falco, Vincenzo Lagano,…

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

June 29, 2026 | Comments Off on Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

Nature Genetics 2026 May [Link] Luana Calabrò, Francesca P Caruso, Alessia Covre, Teresa M R Noviello, Maria F Lofiego, Rossella Tufano, Luigi Ferraro, Piera Grisolia, Antonio De Falco, Vincenzo Lagano,…

Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview

June 26, 2026 | Comments Off on Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview

Thoracic Cancer 2026 April [Link] Raffaella Pagliaro, Beatrice Leonardi, Angela Schiattarella, Grazia Bergameo, Carmine Picone, Adolfo Gallipoli D’Errico, Filippo Scialò, Fabio Perrotta, Maria Luisa De Rimini, Alfonso Fiorelli, Andrea Bianco…

The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma

June 25, 2026 | Comments Off on The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma

The Annals of Thoracic Surgery 2026 July [Link] Jeffrey B Velotta, Anja C Roden, Jonathan Rice, Charles B Simone, Bansari Upadhyay, Pallavi Sood, Daniel L Miller, R Taylor Ripley, Andrea…

Checkpoint kinase 1 protein as a diagnostic marker for pleural mesothelioma

June 24, 2026 | Comments Off on Checkpoint kinase 1 protein as a diagnostic marker for pleural mesothelioma

Journal of the American society of Cytopathology 2026 March 28 [Link] Azadeh Asghari Birbaneh, Christos Meristoudis, Caspar Bundgaard Nielsen, Weronika Maria Szejniuk, Morten Johansen, Peter Derek Christian Leutscher, Vasiliki Panou,…

Regional immunosuppression and associated systemic markers in focally relapsed sarcomatoid mesothelioma: case report

June 23, 2026 | Comments Off on Regional immunosuppression and associated systemic markers in focally relapsed sarcomatoid mesothelioma: case report

Journal for Immunotherapy of Cancer 2026 April 15 [Link] Hely Ollila, Prateek Kulkarni, Hyojin Kim, Pratiti Ankola, Navin K Chintala, Carlos Thomas, Jennifer L Sauter, Michael Offin, Prasad S Adusumilli…

Categories